Darrell Ting Hung Li1, Edward Sai Kam Hui1, Queenie Chan2, Nailin Yao3, Siew-eng Chua4, Grainne M. McAlonan4,5, Shu Leong Ho6, and Henry Ka Fung Mak1
1Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong, Hong Kong, 2Philips Healthcare, Hong Kong, Hong Kong, 3Department of Psychiatry, Yale University, New Haven, CT, United States, 4Department of Psychiatry, The University of Hong Kong, Hong Kong, Hong Kong, 5Department of Forensic and Neurodevelopmental Science, King’s College London, London, United Kingdom, 6Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
Synopsis
Parkinson’s
disease (PD) patients may develop other non-motor comorbidities when the disease
progress. While increased nigral iron was considered as a biomarker of the
disease, it was also believed that iron deposition is associated with the
development of other non-motor symptoms. In this study, magnetic susceptibility
as a surrogate of iron concentration was measured in six major subcortical
brain regions on the QSM images. Increased magnetic susceptibilities were
observed in hippocampus and amygdala of the PD patients with dementia,
suggesting a possible association of iron with the development of dementia
symptom in late stage of PD.Purpose
Late stage Parkinson’s disease (PD)
patients were commonly observed with other non-motor comorbidities such as
dementia and psychosis. While abnormal iron level in the substantia nigra was
clinically accepted as the biomarker of PD
1-3, it was also suggested
that the increased iron deposition could also impair other brain regions and
induced non-motor symptoms along with PD. In this study, we aimed to
investigate the iron level of different subcortical brain regions of the
demented PD patients (PDD) with the aid of the quantitative susceptibility
mapping (QSM) technique.
Methods
MR
susceptibility imaging were performed on 69 subjects, with 11 PDD patients (8
males, mean age ± S.D. = 73 ± 6 years, mean illness duration ± S.D. = 13 ± 8
years), 32 PD patients without other known comorbidities (18 males, mean age ±
S.D. = 63 ± 8 years, mean illness duration ± S.D. = 8 ± 5 years) and 26 healthy
control (15 males, mean age ± S.D. = 62 ± 7 years). All images were acquired by
a Philips 3.0T Achieva TX system. The imaging protocol was as follows: 3D-T1FFE
sequence, TR/TE = 28/23 ms, flip angle = 15°, NEX = 1, FOV = 230 x 230 x 180 mm
3,
reconstructed resolution = 0.45 x 0.45 x 1 mm
3. L1-norm
QSM images were generated from the unwrapped and background-field-removed phase
images with the total variation regularization method
4-5. Same
session 3D-MPRAGE images were affine registered to the magnitude of the susceptibility
images, which were subsequently passed to FSL-FIRST for automatic subcortical
structure segmentation. Six bilateral structures (left and right caudate
nucleus, putamen, pallidum, thalamus, hippocampus and amygdala) were segmented
on each subject’s native space (fig. 1) and were used as the ROI to analyze both
mean estimated volume and the mean magnetic susceptibility of the corresponding
structure.
Results
Age and gender were considered as
covariates and were adjusted in this study. The mean estimated volume of each structure
were compared between the three groups (fig. 2). One-way ANCOVA, after adjusted
for age and gender, showed significant differences for volume of left (p =
0.04) and right putamen (p = 0.023) between the groups. Post-hoc test with
Bonferroni adjustment suggested that volume of left putamen in the PDD group is
smaller than that in the PD group (p = 0.044). Other subcortical brain regions
did not show any significant volume reduction in PD or PDD groups. Mean
magnetic susceptibility of the structures were then compared with the same
approach (fig. 3). The result of one-way ANCOVA showed significant group
differences for left (p < 0.001) and right hippocampus (p = 0.004); left (p
= 0.007) and right thalamus (p = 0.001) and left amygdala (p = 0.021). Post-hoc
test for multiple group comparison suggested higher magnetic susceptibility in
the PDD group than the healthy group in the left (p < 0.001) and right hippocampus
(p = 0.046), left (p = 0.022) and right thalamus (p = 0.034) and the left
amygdala (p = 0.018). PDD group also had higher susceptibility than the PD
group in left hippocampus (p = 0.040).
Discussions
The volumetric analysis suggested no
significant brain atrophy in the subcortical structures concerned. The measured
magnetic susceptibilities in the bilateral hippocampus, bilateral thalamus and
left amygdala were significantly higher in the PDD group when compared to that
in the PD and the healthy control groups, suggesting possible increment of iron
deposition in these brain regions
6. It was also worth noted that
positive susceptibilities were found in the hippocampus and amygdala in the PDD
group, as opposed to the negative susceptibilities in the healthy brain. Increasing
iron load in human brain is believed to be neurotoxic and contributed to
neurodegeneration and neuronal cell death. While hippocampus is associated with
memory function in human brain, the major role of amygdala is to process memory
and emotion. Damage to the two brain nuclei could impair the memory function
and induce dementia-related symptom. This study, by employing the in vivo MRI with QSM method,
demonstrated that the impairment of memory function in the PDD group is
associated with the increased iron load in hippocampus or amygdala, despite the
small sample size of the dementia group recruited in this study. Causal
relationship of abnormal iron deposition and development of dementia in late stage
PD patients or concomitant Alzheimer type neurodegeneration, however, is yet to
be explored.
Conclusion
Abnormal
increment of magnetic susceptibility in the hippocampus and amygdala, reflecting
increased iron level, is associated with the development of dementia symptom in
PD patients.
Acknowledgements
No acknowledgement found.References
1. Du G.,
et al. Quantitative Susceptibility Mapping of the Midbrain in Parkinson’s
Disease. Mov Disord. 2015 Sep 12.
2. Murakami
Y., et al. Usefulness of Quantitative Susceptibility Mapping for Diagnosis of
Parkinson’s Disease. Am J Neuroradiol 2015 Jun; 36(6): 1102 – 08
3. Barbosa
JH., et al. Quantifying brain iron deposition in patients with Parkinson’s
disease using quantitative susceptibility mapping, R2 and R2*. Magn Reson
Imaging. 2015 Jun;33(5):559-65.
4. Bilgic
B, et al. MRI estimates of brain iron concentration in normal aging using
quantitative susceptibility mapping. NeuroImage 2012; 59: 2625-2635.
5. Bilgic
B, et al. Fast Quantitative Susceptibility Mapping with L1-Regularization and
Automatic Parameter Selection. Magn Reson Med. 2014 Nov; 72(5): 1444-59.
6. Langkammer
C, et al. Quantitative Susceptibiliy Mapping (QSM) as a means to measure brain
iron? A postmortem validation study. NeuroImage 2012; 62: 1593 – 1599.